this suggests the possibility of developing a series of antibiotic regimes using these amplifiers ( or the large number of derivative compounds also likely to be active ) where the therapeutic index is determined by the properties of the amplifier chosen rather than of the phleomycin or the bleomycin .
C0031559
phleomycin
C0005740
bleomycin